Selective endothelin (ET)-A receptor antagonist and dual ET-A/B receptor antagonist are effective in preventing the decrease in VEGF signaling and inadequate coronary collateral development in the diabetic hearts
| Autor: | Nobutake Shimojo, Seiji Maeda, Sohel Zaedi, Kazutaka Aonuma, Satoshi Homma, Taro Mizutani, Tomoko Yokota, Satoshi Sakai, Yumi Miyauchi, Takashi Miyauchi, Subrina Jesmin |
|---|---|
| Jazyk: | angličtina |
| Předmět: |
medicine.medical_specialty
medicine.drug_class business.industry Biochemistry Genetics and Molecular Biology(all) General Medicine Endothelin et Receptor antagonist General Biochemistry Genetics and Molecular Biology Pharmacology Toxicology and Pharmaceutics(all) Endocrinology Internal medicine medicine VEGF signaling General Pharmacology Toxicology and Pharmaceutics business |
| Zdroj: | Life Sciences. (25-26):e65-e66 |
| ISSN: | 0024-3205 |
| DOI: | 10.1016/j.lfs.2014.01.022 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|